<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Synthesis and Biological Evaluation of Substituted 3-anilino-quinolin-2(1H)-ones as PDK1 Inhibitors

avondale-bepress.context-key6888295
avondale-bepress.submission-pathsci_math_papers/62
avondale.facultyScience
avondale.reporting.isPeerReviewedPeer Reviewed
avondale.reporting.versionPublished Version
dc.contributor.authorAbbott, Belinda M.
dc.contributor.authorDeady, Leslie W.
dc.contributor.authorWilson, David J.
dc.contributor.authorBrzozowski, Martin
dc.contributor.authorO'Brien, Nathan J.
dc.date.accessioned2023-11-01T00:39:24Z
dc.date.available2023-11-01T00:39:24Z
dc.date.issued2014-07-15
dc.date.submitted2015-03-23T21:53:04Z
dc.description.abstract<p>PDK1 is an important regulator of the PI3K/Akt pathway, which has been found frequently activated in a large number of human cancers. Herein we described the preparation of novel substituted 3-anilino-quinolin-2(1<em>H</em>)-ones as PDK1 inhibitors. The synthesis is based around a Buchwald–Hartwig cross-coupling of various 3-bromo-6-substituted-quinolin-2(1<em>H</em>)-ones with three different functionalised anilines. The modular nature of the designed synthesis allowed access to a series of novel inhibitors through derivatisation of a late-stage intermediate. All compounds were screened against isolated PDK1 enzyme, with modest inhibition observed.</p>
dc.identifier.citation<p>O'Brien, N. J., Brzozowski, M., Wilson, D. J., Deady, L. W., & Abbott, B. M. (2014). Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors. <em>Bioorganic and Medicinal Chemistry, 22</em>(14), 3781-3790. doi:10.1016/j.bmc.2014.04.037</p>
dc.identifier.doihttps://doi.org/10.1016/j.bmc.2014.04.037
dc.identifier.issn0968-0896
dc.identifier.urihttps://research.avondale.edu.au/handle/1897/06888295
dc.language.isoen_us
dc.provenance<p>This article was originally published as:</p> <p>O'Brien, N. J., Brzozowski, M., Wilson, D. J., Deady, L. W., & Abbott, B. M. (2014). Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors. <em>Bioorganic and Medicinal Chemistry, 22</em>(14), 3781-3790. doi:10.1016/j.bmc.2014.04.037</p> <p>ISSN:0968-0896</p>
dc.relation.ispartofBioorganic and Medicinal Chemistry
dc.rights<p>Due to copyright restrictions this article is unavailable for download.</p> <p>Copyright © 2014 Published by Elsevier Ltd. All rights reserved.</p>
dc.subject3-Phosphoinositide-dependent kinase 1 (PDK1)
dc.subject3-Anilino-quinolin-2(1H)-ones Inhibitor
dc.subjectBuchwald–Hartwig cross-coupling
dc.subjectCross-coupling
dc.titleSynthesis and Biological Evaluation of Substituted 3-anilino-quinolin-2(1H)-ones as PDK1 Inhibitors
dc.typeJournal Article

Files

Avondale University acknowledges our Sovereign God as Creator and Provider of all things. We respectfully acknowledge the Awabakal and Darramuragal people as the traditional custodians of the lands on which we live, work, study and worship across our Lake Macquarie and Sydney campuses. We pay our respects to Elders past, present and emerging, and extend that respect to all First Nations People.

Aboriginal Peoples are advised the Library Collection contains images, voices and names of deceased people in physical and online resources. The Library recognises the significance of the traditional cultural knowledges contained within its Collection. The Library acknowledge some materials contain language that may not reflect current attitudes, was published without consent or recognition, or, is offensive. These materials reflect the views of the authors and/or the period in which they were produced and do not represent the views of the Library.

Avondale University is a member of the worldwide Seventh-day Adventist system of universities and colleges.

CRICOS Provider No.: 02731D. RTO: 91191. TEQSA: PRV12015. ABN: 53 108 186 401.

© Avondale University Ltd 2026